Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: High-Throughput Measurement of Intracellular ROS Levels in Hepatocellular Lines
Published on: January 19, 2024
Nanotherapy and Reactive Oxygen Species (ROS) in Cancer: A Novel Perspective
Peter Brenneisen1, Andreas S Reichert2
1Institute of Biochemistry and Molecular Biology I, Medical Faculty, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany. peter.brenneisen@hhu.de.
Abstract:
The incidence of numerous types of cancer has been increasing over recent years, representing the second-most frequent cause of death after cardiovascular diseases. Even though, the number of effective anticancer drugs is increasing as well, a large number of patients suffer from severe side effects (e.g., cardiomyopathies) caused by these drugs. This adversely affects the patients' well-being and quality of life. On the molecular level, tumor cells that survive treatment modalities can become chemotherapy-resistant. In addition, adverse impacts on normal (healthy, stromal) cells occur concomitantly. Strategies that minimize these negative impacts on normal cells and which at the same time target tumor cells efficiently are needed. Recent studies suggest that redox-based combinational nanotherapies may represent one option in this direction. Here, we discuss recent advances in the application of nanoparticles, alone or in combination with other drugs, as a promising anticancer tool. Such novel strategies could well minimize harmful side effects and improve patients' health prognoses.
Insights
Nanoparticle-based cancer treatments show promise for reducing severe side effects and overcoming drug resistance. These novel nanotherapies aim to improve patient outcomes by targeting tumor cells more effectively while sparing healthy tissues.
Area of Science:
- Oncology
- Nanomedicine
- Drug Development
Background:
- Cancer incidence is rising globally, making it the second leading cause of death.
- Current anticancer drugs cause severe side effects and chemotherapy resistance, impacting patient quality of life.
- There is a critical need for cancer treatment strategies that minimize harm to healthy cells and enhance tumor targeting.
Purpose of the Study:
- To review recent advancements in nanoparticle applications for cancer therapy.
- To explore the potential of combinational nanotherapies in improving treatment efficacy and reducing toxicity.
- To highlight strategies for minimizing adverse effects on normal cells during cancer treatment.
Main Methods:
- Review of recent scientific literature on nanoparticle-based cancer treatments.
- Analysis of studies employing nanoparticles alone or in combination with other therapeutic agents.
- Discussion of redox-based combinational nanotherapies as a novel approach.
Main Results:
- Nanoparticles demonstrate potential as effective anticancer tools, either independently or in combination therapies.
- Emerging nanotherapies show promise in mitigating severe side effects associated with conventional chemotherapy.
- These advanced strategies may lead to improved patient prognoses and reduced treatment-related toxicities.
Conclusions:
- Nanoparticle-based therapies offer a promising avenue for more targeted and less toxic cancer treatment.
- Combinational nanotherapies, particularly redox-based approaches, represent a significant advancement in oncology.
- Further research and development in this area could revolutionize cancer care and improve patient well-being.
Related Concept Videos
What is a Species?
Keystone Species
Formation of Species
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
The Behavioral Perspective on Personality

